Rocuronium Bromide Injection
Product Images NDC 43547-531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43547-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figures 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
This appears to be a chart or graph showing the number of minutes against different dosages for different age groups. The age group ranges from 3 months to over 65 years old. The dosages are measured in mg/kg. It seems that the graph is displaying the amount of time for the medication to take effect (in minutes) for different age groups and dosages.*
FDA Label Image

Figure 3 (Image 04)

FDA Label Image

50 mg/5 mL Vial (Image 05)

50 mg/5 mL Vial (Image 05)
Rocuronium Bromide Injection is a sterile and non-pyrogenic medication intended for intravenous use only. The medication is contained in a multi-dose vial with 50mg/5ml concentration (10mg/mL) and has the NDC code 43547-530-01. The text also includes various alphanumeric codes and symbols which do not provide any additional information about the medication.*
FDA Label Image

50 mg/5 mL Carton (Image 06)

FDA Label Image

Peel Off Label 10 mg/ml (Image 07)

FDA Label Image

100 mg/10 mL Vial (Image 08)

100 mg/10 mL Vial (Image 08)
This product is a 100mg/10mL injection of Rocuronium Bromide. It is a sterile and nonpyrogenic solution made available in a multi-dose vial. The product is intended for intravenous (IV) use only and is used as a paralyzing agent that may cause respiratory arrest. The use of artificial respiration should be made to facilitate breathing in such cases. This product is available immediately for use in facilities.*
FDA Label Image

100 mg/10 mL Carton (Image 09)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.